Abstract
The biochemical and clinical efficacy of intravenous augmentation therapy in α1-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.
Cite
CITATION STYLE
APA
Stoller, J. K., & Aboussouan, L. S. (2004, August). α1-antitrypsin deficiency·5: Intravenous augmentation therapy: Current understanding. Thorax. https://doi.org/10.1136/thx.2003.006544
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free